Radiology’s Value Chain
- 1 April 2012
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 263 (1) , 243-252
Abstract
A diagnostic radiology value chain is constructed to define its main components, all of which are vulnerable to change, because digitization has caused disaggregation of the chain. Some components afford opportunities to improve productivity, some add value, while some face outsourcing to lower labor cost and to information technology substitutes, raising commoditization risks. Digital image information, because it can be competitive at smaller economies of scale, allows faster, differential rates of technological innovation of components, initiating a centralization-to-decentralization technology trend. Digitization, having triggered disaggregation of radiology's professional service model, may soon usher in an information business model. This means moving from a mind-set of "reading images" to an orientation of creating and organizing information for greater accuracy, faster speed, and lower cost in medical decision making. Information businesses view value chain investments differently than do small professional services. In the former model, producing a better business product will extend image interpretation beyond a radiologist's personal fund of knowledge to encompass expanding external imaging databases. A follow-on expansion with integration of image and molecular information into a report will offer new value in medical decision making. Improved interpretation plus new integration will enrich and diversify radiology's key service products, the report and consultation. A more robust, information-rich report derived from a "systems" and "computational" radiology approach will be facilitated by a transition from a professional service to an information business. Under health care reform, radiology will transition its emphasis from volume to greater value. Radiology's future brightens with the adoption of a philosophy of offering information rather than "reads" for decision making. Staunchly defending the status quo via turf wars is unlikely to constitute a forward-looking, competitive strategy.Keywords
This publication has 17 references indexed in Scilit:
- Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamideEuropean Radiology, 2011
- High Order Diffusion Tensor Imaging in Human GlioblastomaAcademic Radiology, 2011
- Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumabJournal of Neuro-Oncology, 2011
- Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated GlioblastomaAmerican Journal of Neuroradiology, 2011
- Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumabNeuro-Oncology, 2011
- Spatially quantifying microscopic tumor invasion and proliferation using a voxel‐wise solution to a glioma growth model and serial diffusion MRIMagnetic Resonance in Medicine, 2010
- Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomasJournal of Neuro-Oncology, 2010
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences, 2008
- Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2007
- Decoding global gene expression programs in liver cancer by noninvasive imagingNature Biotechnology, 2007